Pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Monday a dividend of USD1.73 per share on outstanding common stock for the first quarter of 2026.
This is an increase from the USD1.50 per share paid in each quarter of the prior year.
The new dividend will be paid on 10 March 2026 to shareholders of record at 13 February 2026.
Alvotech reports positive PK study results for AVT80 biosimilar candidate
Inspiration Healthcare secures US purchasing agreement to drive Airon growth
West to sell SmartDose 3.5mL On-Body Delivery System rights to AbbVie for USD112.5m
Citius Pharmaceuticals reports full-year financial results
Sanofi receives FDA complete response letter for tolebrutinib in progressive MS
Abbott announces quarterly common dividend increase
Amgen announces Q1 2026 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Perrigo to pay quarterly dividend of USD0.290 per share
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio